The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 17, 2021 | Walker Paul Edward | Director | Disposed to issuer(D) | 40K | — | $0 |
| Nov 17, 2021 | Walker Paul Edward | Director | Disposed to issuer(D) | 850K | — | $0 |
| Nov 17, 2021 | Walker Paul Edward | Director | Disposed to issuer(D) | 6.8M | — | $0 |
| Nov 17, 2021 | Walker Paul Edward | Director | Disposed to issuer(D) | 5.4M | — | $0 |
| Nov 17, 2021 | Walker Paul Edward | Director | Disposed to issuer(D) | 5.7M | — | $0 |
| Nov 17, 2021 | Skvarka Jan | President and CEO, Director | Disposed to issuer(D) | 197K | — | $0 |
| Nov 17, 2021 | Skvarka Jan | President and CEO, Director | Disposed to issuer(D) | 1.2M | — | $0 |
| Nov 17, 2021 | Skvarka Jan | President and CEO, Director | Disposed to issuer(D) | 600K | — | $0 |
| Nov 17, 2021 | Tayton-Martin Helen Katrina | Director | Disposed to issuer(D) | 40K | — | $0 |
| Nov 17, 2021 | Tayton-Martin Helen Katrina | Director | Disposed to issuer(D) | 498K | — | — |
| Nov 17, 2021 | Uger Robert | Chief Scientific Officer | Disposed to issuer(D) | 250K | — | $0 |
| Nov 17, 2021 | Uger Robert | Chief Scientific Officer | Disposed to issuer(D) | 29K | — | $0 |
| Nov 17, 2021 | Uger Robert | Chief Scientific Officer | Disposed to issuer(D) | 23K | — | $0 |
| Nov 17, 2021 | Uger Robert | Chief Scientific Officer | Disposed to issuer(D) | 5K | — | $0 |
| Nov 17, 2021 | Uger Robert | Chief Scientific Officer | Disposed to issuer(D) | 58K | — | $0 |
| Nov 17, 2021 | Uger Robert | Chief Scientific Officer | Disposed to issuer(D) | 102K | — | $0 |
| Nov 17, 2021 | Petrova Penka | Chief Development Officer | Disposed to issuer(D) | 140K | — | $0 |
| Nov 17, 2021 | Petrova Penka | Chief Development Officer | Disposed to issuer(D) | 84K | — | $0 |
| Nov 17, 2021 | Petrova Penka | Chief Development Officer | Disposed to issuer(D) | 49K | — | $0 |
| Nov 17, 2021 | Petrova Penka | Chief Development Officer | Disposed to issuer(D) | 5K | — | $0 |
| Nov 17, 2021 | Petrova Penka | Chief Development Officer | Disposed to issuer(D) | 39K | — | $0 |
| Nov 17, 2021 | Bruns Ingmar | Chief Medical Officer | Disposed to issuer(D) | 400K | — | $0 |
| Nov 17, 2021 | Mackey Catherine J | Director | Disposed to issuer(D) | 67K | — | $0 |
| Nov 17, 2021 | Looker Benjamin | General Counsel | Disposed to issuer(D) | 190K | — | $0 |
| Nov 17, 2021 | Kamarck Michael E. | Director | Disposed to issuer(D) | 67K | — | $0 |
| Nov 17, 2021 | Parsons James T. | Chief Financial Officer | Disposed to issuer(D) | 30K | — | $0 |
| Nov 17, 2021 | Parsons James T. | Chief Financial Officer | Disposed to issuer(D) | 30K | — | $0 |
| Nov 17, 2021 | Parsons James T. | Chief Financial Officer | Disposed to issuer(D) | 24K | — | $0 |
| Nov 17, 2021 | Parsons James T. | Chief Financial Officer | Disposed to issuer(D) | 36K | — | $0 |
| Nov 17, 2021 | Parsons James T. | Chief Financial Officer | Disposed to issuer(D) | 6K | — | $0 |
| Nov 17, 2021 | Parsons James T. | Chief Financial Officer | Disposed to issuer(D) | 60K | — | $0 |
| Nov 17, 2021 | Parsons James T. | Chief Financial Officer | Disposed to issuer(D) | 180K | — | $0 |
| Nov 17, 2021 | Parsons James T. | Chief Financial Officer | Disposed to issuer(D) | 95K | — | $0 |
| Nov 17, 2021 | Beshar Luke M | Director | Disposed to issuer(D) | 40K | — | $0 |
| Nov 17, 2021 | Beshar Luke M | Director | Disposed to issuer(D) | 548K | — | — |
| Nov 17, 2021 | Beshar Luke M | Director | Disposed to issuer(D) | 7K | — | $0 |
| Nov 17, 2021 | Harrison Rosemary | See Remarks | Disposed to issuer(D) | 75 | — | — |
| Nov 17, 2021 | Harrison Rosemary | See Remarks | Disposed to issuer(D) | 180K | — | $0 |
| Nov 17, 2021 | Myers Scott Dunseth | Director | Disposed to issuer(D) | 67K | — | $0 |
| Nov 17, 2021 | Pucci Paolo | Director | Disposed to issuer(D) | 67K | — | $0 |
| Jul 7, 2021 | Uger Robert | Chief Scientific Officer | Option exercise(M) | 4K | — | $0 |
| Jul 7, 2021 | Uger Robert | Chief Scientific Officer | Option exercise(M) | 4K | $0.30 | $1K |
| Jul 7, 2021 | Uger Robert | Chief Scientific Officer | Sell(S) | 4K | $9.00 | $33K |
| Jul 1, 2021 | Mackey Catherine J | Director | Grant(A) | 67K | — | $0 |
| Jun 7, 2021 | Uger Robert | Chief Scientific Officer | Option exercise(M) | 4K | — | $0 |
| Jun 7, 2021 | Uger Robert | Chief Scientific Officer | Sell(S) | 4K | $8.27 | $30K |
| Jun 7, 2021 | Uger Robert | Chief Scientific Officer | Option exercise(M) | 4K | $0.32 | $1K |
| May 12, 2021 | Skvarka Jan | President and CEO, Director | Option exercise(M) | 24K | — | $0 |
| May 12, 2021 | Skvarka Jan | President and CEO, Director | Option exercise(M) | 24K | $0.31 | $7K |
| May 12, 2021 | Skvarka Jan | President and CEO, Director | Sell(S) | 24K | $9.24 | $220K |
| May 11, 2021 | Skvarka Jan | President and CEO, Director | Option exercise(M) | 19K | — | $0 |
| May 11, 2021 | Skvarka Jan | President and CEO, Director | Option exercise(M) | 88K | — | $0 |
| May 11, 2021 | Skvarka Jan | President and CEO, Director | Option exercise(M) | 88K | $0.45 | $39K |
| May 11, 2021 | Skvarka Jan | President and CEO, Director | Option exercise(M) | 19K | $0.31 | $6K |
| May 11, 2021 | Skvarka Jan | President and CEO, Director | Sell(S) | 107K | $9.20 | $982K |
| May 7, 2021 | Uger Robert | Chief Scientific Officer | Option exercise(M) | 4K | — | $0 |
| May 7, 2021 | Uger Robert | Chief Scientific Officer | Option exercise(M) | 4K | $0.31 | $1K |
| May 7, 2021 | Uger Robert | Chief Scientific Officer | Sell(S) | 4K | $9.30 | $34K |
| May 3, 2021 | Looker Benjamin | General Counsel | Grant(A) | 190K | — | $0 |
| May 3, 2021 | Myers Scott Dunseth | Director | Grant(A) | 67K | — | $0 |
| Apr 8, 2021 | Petrova Penka | Chief Development Officer | Option exercise(M) | 3K | — | $0 |
| Apr 8, 2021 | Petrova Penka | Chief Development Officer | Option exercise(M) | 3K | — | $0 |
| Apr 8, 2021 | Petrova Penka | Chief Development Officer | Sell(S) | 5K | $11.09 | $59K |
| Apr 8, 2021 | Petrova Penka | Chief Development Officer | Option exercise(M) | 3K | $3.36 | $9K |
| Apr 8, 2021 | Petrova Penka | Chief Development Officer | Option exercise(M) | 3K | $0.30 | $812 |
| Apr 7, 2021 | Uger Robert | Chief Scientific Officer | Option exercise(M) | 4K | — | $0 |
| Apr 7, 2021 | Uger Robert | Chief Scientific Officer | Option exercise(M) | 4K | $0.30 | $1K |
| Apr 7, 2021 | Uger Robert | Chief Scientific Officer | Sell(S) | 4K | $10.82 | $39K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).